News

3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over Pfizer
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”
We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...
Pfizer subsidiary receives A2 rating from Moody’s with stable outlook
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Investing Snacks12h
Pfizer Slims Its Wallet, Terns Tries to Fly Anyway
BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...
EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer
Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...